epidemic
WHO: Ebola Emergency Over
WHO: Ebola Emergency Over
Tracy Vence | Mar 30, 2016
While additional flare-ups may occur, the World Health Organization says countries now “have the capacity to respond rapidly to new virus emergences.”
Predicting Zika’s Potential Path
Predicting Zika’s Potential Path
Bob Grant | Mar 17, 2016
The mosquitoes that carry the virus could spread to US cities this summer, with travelers returning from Zika-infected regions contributing to the disease’s spread.
Mapping Zika with Google
Mapping Zika with Google
Catherine Offord | Mar 4, 2016
The tech giant contributes funding and technical support to monitor and respond to the spread of Zika infection across Latin America.
Zika Update
Zika Update
Kerry Grens | Jan 28, 2016
The virus continues to spread as countries issue pregnancy advisories and drug firms pick up on vaccine development.
New Tests for Zika in the Works
New Tests for Zika in the Works
Kerry Grens | Jan 25, 2016
To answer questions about the risks of Zika virus infection, researchers need better diagnostics.
Cross-Reactive Ebola Antibodies
Cross-Reactive Ebola Antibodies
Anna Azvolinsky | Jan 21, 2016
Human monoclonal antibodies induced during Ebola infection are able to neutralize related viral species, scientists show. 
Planning for the Next Ebola Outbreak
Planning for the Next Ebola Outbreak
Bob Grant | Jan 20, 2016
A public-health nonprofit and an international drugmaker team up to stockpile hundreds of thousands of doses of a promising vaccine and to speed along the approval process.
The Evolving Face of Obesity
The Evolving Face of Obesity
The Scientist Staff | Nov 1, 2015
Researchers are striving to understand exactly what has made the global population get so fat so fast.
Ebola Vax Success
Ebola Vax Success
Jef Akst | Aug 3, 2015
An experimental vaccine against Ebola virus disease may completely protect people against infection, according to a clinical study in Guinea.
HHS Partners on Ebola Drug
HHS Partners on Ebola Drug
Jef Akst | Jul 22, 2015
The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.